Advanced Micro Devices, Inc. - Common Stock (AMD)
504.59
+21.58 (4.47%)
NASDAQ· Last Trade: Aug 14th, 2:04 PM EDT
Detailed Quote
| Previous Close | 483.01 |
|---|---|
| Open | 487.60 |
| Bid | 504.41 |
| Ask | 504.66 |
| Day's Range | 483.20 - 511.47 |
| 52 Week Range | 149.22 - 584.73 |
| Volume | 16,649,133 |
| Market Cap | 612.05B |
| PE Ratio (TTM) | 190.41 |
| EPS (TTM) | 2.6 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 28,334,910 |
Chart
About Advanced Micro Devices, Inc. - Common Stock (AMD)
Advanced Micro Devices is a leading global semiconductor company that designs and manufactures computing and graphics solutions for a wide range of applications. The company is known for its innovative microprocessors, graphics cards, and system-on-chip products, which are used in personal computers, servers, and embedded systems. AMD focuses on high-performance computing, gaming, and data center markets, offering advanced technologies that compete with those of other major players in the industry. By delivering cutting-edge products that push the boundaries of processing power and efficiency, AMD plays a critical role in driving technological advancements and enhancing user experiences across various platforms. Read More
News & Press Releases
What Happened? Shares of semiconductor company Semtech (NASDAQ:SMTC) jumped 3.5% in the afternoon session after Needham maintained its 'Buy' rating and $200 ...
Via StockStory · August 14, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · August 14, 2026
NVIDIA lines up over $500 billion in third-party capital, backed by BlackRock, Apollo, Brookfield, and Goldman Sachs, to finance AI GPU capacity through securitized loans.
Via MarketBeat · August 14, 2026
Oncobiologics (NASDAQ:OTLK) said it is preparing for the U.S. commercial launch of LYTENAVA after the Food and Drug Administration approved the product as the only FDA-approved ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration, or wet AMD, in the United
Via MarketBeat · August 14, 2026
AI Earnings Split: Accelerating Growers Rewarded, Cloud Bellwether Sells Offchartmill.com
Via Chartmill · August 13, 2026
Cerebras shares fell after Q2 results, but strong RPO growth past $25 billion, analyst Moderate Buy ratings, and expanding inference demand suggest the pullback may be overdone.
Via MarketBeat · August 14, 2026
AMD stock ticks up as the chipmaker plans a record $5B bond sale to accelerate AI server expansion and fund data-center growth.
Via Benzinga · August 14, 2026
Mark Zuckerberg's AI manifesto hints at multiple investment opportunities.
Via The Motley Fool · August 14, 2026
It has lost more than half its value in less than a year.
Via The Motley Fool · August 14, 2026
Riot Platforms posted a $237.2M net loss, but a 20-year, $9.1B Anthropic data center lease at Rockdale signals its pivot from crypto mining to AI hosting infrastructure.
Via MarketBeat · August 13, 2026
The chipmaker has had a great year, but its valuation has gotten ahead of its results.
Via The Motley Fool · August 13, 2026
Advanced Micro Devices plans a record $5 billion bond sale to fund aggressive AI infrastructure investments, refinance debt, and power key partnerships with Microsoft and Anthropic.
Via Benzinga · August 13, 2026
AMD details massive AI growth plans, targeting 80%+ server revenue growth in H2 2026 backed by major cloud commitments.
Via Benzinga · August 13, 2026
Both companies are navigating the AI era from positions of strength, but their growth profiles and risk levels tell very different stories.
Via The Motley Fool · August 12, 2026
Cerebras Systems (NASDAQ:CBRS) reported record second-quarter core revenue and raised its full-year outlook, as the AI infrastructure company said it is expanding data-center capacity, manufacturing output and customer deployments to support anticipated growth beginning in 2027.
Chief Executive Off
Via MarketBeat · August 12, 2026
AMD boasts superior margins and lower leverage, while AppLovin trades at a fraction of the valuation multiple despite explosive growth.
Via The Motley Fool · August 12, 2026
What Happened? A number of stocks jumped in the afternoon session after a wave of upbeat earnings reports and bullish forecasts from key industry players sig...
Via StockStory · August 12, 2026
What Happened? A number of stocks jumped in the afternoon session after a wave of upbeat earnings reports and bullish forecasts from key industry players sig...
Via StockStory · August 12, 2026
What Happened? A number of stocks jumped in the afternoon session after a wave of upbeat earnings reports and bullish forecasts from key industry players sig...
Via StockStory · August 12, 2026
AMD's explosive growth and fortress balance sheet contrast sharply with Alphabet's valuation discount and cash generation, a choice between momentum and value.
Via The Motley Fool · August 12, 2026
AMD stock jumps 3% as AI infrastructure demand grows. Explore key price targets, technical indicators, and analyst ratings for AMD.
Via Benzinga · August 12, 2026
Cerebras reports Q2 earnings today as prediction-market traders bet on what CEO Andrew Feldman will say about OpenAI, AMD, AWS and key AI partnerships.
Via Benzinga · August 12, 2026
Former AMD CVP Patrick Moorhead compares Nvidia’s AI dominance to peak Intel and the trap of 'financial engineering.'
Via Benzinga · August 12, 2026
AMD and Nvidia are the market leaders for designing artificial intelligence (AI) GPUs.
Via The Motley Fool · August 12, 2026
As hyperscalers invest hundreds of trillions in AI infrastructure in the coming years, these two companies are top beneficiaries.
Via The Motley Fool · August 12, 2026
